Search - tctmd.com

Displaying 81 - 100 of 606

Sort: Relevancy | Date

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Conference News ACC 2023

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

L.A. McKeown

March 09, 2023

News Conference News ACC 2023

BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF

L.A. McKeown

March 06, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Daily News

Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM

Yael L. Maxwell

February 15, 2023

News Daily News

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Michael O'Riordan

January 20, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Daily News

Top Coronary Artery Disease News of 2022

Yael L. Maxwell

December 29, 2022

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

Todd Neale

December 16, 2022

News Daily News

Nuisance Bleeds on DAPT Not Just an Annoyance: TALOS-AMI Analysis

Caitlin E. Cox

November 30, 2022

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Todd Neale

November 21, 2022

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

Advertisement

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

March 2023 News Roundup

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Top Coronary Artery Disease News of 2022

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

Nuisance Bleeds on DAPT Not Just an Annoyance: TALOS-AMI Analysis

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Many STEMI Patients Not Treated Within National Time Goals

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content